4//SEC Filing
Khadder Nicholas 4
Accession 0001162194-22-000060
CIK 0001162194other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 8:16 PM ET
Size
15.6 KB
Accession
0001162194-22-000060
Insider Transaction Report
Form 4
Khadder Nicholas
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-05-20+4,063→ 86,454 total - Exercise/Conversion
Common Stock
2022-05-20+15,000→ 101,454 total - Exercise/Conversion
Common Stock
2022-05-20+9,846→ 111,300 total - Tax Payment
Common Stock
2022-05-20−14,161→ 97,139 total - Exercise/Conversion
Restricted Stock Units
2022-05-20−4,063→ 32,500 total→ Common Stock (4,063 underlying) - Exercise/Conversion
Restricted Stock Units
2022-05-20−9,846→ 29,541 total→ Common Stock (9,846 underlying) - Exercise/Conversion
Restricted Stock Units
2022-05-20−15,000→ 15,000 total→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
- [F2]On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
- [F3]On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.
- [F4]On April 20, 2021, the Reporting Person was granted 39,387 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.
Documents
Issuer
STANDARD BIOTOOLS INC.
CIK 0001162194
Entity typeother
Related Parties
1- filerCIK 0001598911
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 8:16 PM ET
- Size
- 15.6 KB